BSX BOSTON SCIENTIFIC CORP

NYSE bostonscientific.com


$ 100.94 $ 0.00 (0 %)    

Monday, 03-Nov-2025 08:26:37 EST
QQQ $ 633.66 $ 0.00 (0 %)
DIA $ 475.53 $ 0.00 (0 %)
SPY $ 684.47 $ 0.00 (0 %)
TLT $ 89.66 $ 0.00 (0 %)
GLD $ 369.50 $ 0.00 (0 %)
$ 100.72
$ 100.41
$ 100.52 x 1
$ 100.89 x 100
-- - --
$ 83.50 - $ 109.50
7,273,897
na
149.24B
$ 0.83
$ 59.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 11-01-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-23-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 07-30-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 10-29-2018 09-30-2018 10-Q
30 07-31-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-20-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-boston-scientific-raises-price-target-to-130

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target fro...

 wells-fargo-maintains-overweight-on-boston-scientific-raises-price-target-to-125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...

 morgan-stanley-maintains-overweight-on-boston-scientific-raises-price-target-to-130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...

 tech-stocks-drop-netflix-sinks-10-on-worst-day-since-2022-whats-moving-markets-wednesday

Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade t...

 btig-reiterates-buy-on-boston-scientific-maintains-132-price-target

BTIG analyst Marie Thibault reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $132 price target.

 boston-scientific-gains-momentum-as-growth-broadens-goldman-sachs-says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results a...

 boston-scientific-jumps-on-strong-guidance-heart-devices-fuel-topline-growth

Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong se...

 boston-scientific-to-acquire-nalu-medical-in-600-million-pain-relief-deal

Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first half ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION